Neuroscientific Biopharmaceuticals (ASX:NSB) Price-to-Operating-Cash-Flow : (As of May. 05, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-05-05), Neuroscientific Biopharmaceuticals's share price is A$0.055. Neuroscientific Biopharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00. Hence, Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:NSB's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.265
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Neuroscientific Biopharmaceuticals's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 18.00% per year.

During the past 5 years, Neuroscientific Biopharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 18.00% per year. The lowest was -33.90% per year. And the median was -7.95% per year.

Neuroscientific Biopharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Price-to-Operating-Cash-Flow Chart

Neuroscientific Biopharmaceuticals Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Neuroscientific Biopharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Neuroscientific Biopharmaceuticals Price-to-Operating-Cash-Flow Calculation

Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.055	/	0
	=

Neuroscientific Biopharmaceuticals's Share Price of today is A$0.055.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Neuroscientific Biopharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Neuroscientific Biopharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011

Website

https://www.neuroscientific.com

Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines